For immediate release |
9 August 2011 |
Alliance Pharma plc
TR-1: Notification of major interest in shares
1. Identity of the issuer or the underlying issuer |
Alliance Pharma plc |
|||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
Yes |
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
n/a |
|||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
n/a |
|||
An event changing the breakdown of voting rights |
n/a |
|||
Other (please specify): |
On market transfer between direct and indirect funds |
n/a |
||
3. Full name of person(s) subject to the |
Royal Bank of Canada |
|||
4. Full name of shareholder(s) |
Roy Nominees Limited |
|||
5. Date of the transaction and date on |
03 August 2011 |
|||
6. Date on which issuer notified: |
05 August 2011 |
|||
7. Threshold(s) that is/are crossed or |
10%
|
|||
8. Notified details: |
||||||||||||||||
A: Voting rights attached to shares |
||||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
||||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights |
||||||||||||
Direct |
Direct |
Indirect |
Direct |
Indirect |
||||||||||||
Ordinary GBP 0.01 shares ISIN GB0031030819 |
23,001,088 |
23,001,088 |
24,001,088 |
|
24,001,088 |
|
10% |
|||||||||
|
||||||||||||||||
|
||||||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
||||||||||||
|
|
|
|
|
||||||||||||
|
||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Exercise price |
Expiration date |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights
|
|||||||||||
|
|
|
|
|
Nominal |
Delta |
||||||||||
|
|
|||||||||||||||
|
||||||||||||||||
Total (A+B+C) |
||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
24,001,088 |
10% |
|||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
||
The shares are held in the name Roy Nominees Limited for the benefit of trusts administered by RBC Trustees (CI) Limited and RBC cees Trustee Limited which are wholly owned by its ultimate parent, Royal Bank of Canada. |
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
|
|
11. Number of voting rights proxy holder will cease |
|
|
12. Date on which proxy holder will cease to hold |
|
|
|
||
|
|
|
14. Contact name: |
Scott Roberts
|
|
15. Contact telephone number: |
01534 602971 |
|